Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Isoxsuprine hydrochloride
Cat. No.:
OB0225LY-0220
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Isoxsuprine hydrochloride is a beta-adrenergic agonist and a smooth muscle relaxant.
Synonym:
Duvadilan; Isolait; 579-56-6; Isoxsuprine HCl; Duviculine; Benzenemethanol,4-hydroxy-a-[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]-, hydrochloride; 4-(1-Hydroxy-2-((1-phenoxypropan-2-yl)amino)propyl)phenol hydrochloride
CAS No.:
579-56-6
Compound CID:
11368
Formula:
C18H24ClNO3
Formula Weight:
337.84
Specification
Relative Density:
1.146 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Isoxsuprine hydrochloride can be used for blood circulation studies.
Library Information
Targets:
iGluR; Adrenergic receptor
Receptors:
iGluR; β-Adrenergic receptor
Pathways:
GPCR/G protein; Neuronal signaling; Membrane transporter/Ion channel
Plate Number:
AOCL-3
Plate Location:
g4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 133.2 mM
Water Max Solubility:
11.8 mM
